Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L)’s Allogene Therapeutics ALLO Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ALLO Stock Details ALLO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$278K	Buy
2025 Q4	$54.5K	Buy
2022 Q3	–	Sell
2022 Q2	$526K	Buy